A strategy to mitigate toxicities associated with AAV doses of 1E14 vg/kg or higher by enabling repeated vector administrations at 5E13 vg/kg

P. O. Ilyinskii, C. J. Roy, A. M. Michaud, G. L. Rizzo, T. Capela,S. S. Leung,T. K. Kishimoto

HUMAN GENE THERAPY(2022)

Cited 0|Views5
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined